Table 1 Geographic distribution of the respondents with information on laboratories and clinicians showing (i) the geographic distribution of the respondents, (ii) the classification of laboratories as competent or expert and (iii) the clinical setting of the clinicians (N.a.: not applicable; Total completed: number of respondents that completed the whole survey)

From: Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey